NCT04544033View on ClinicalTrials.gov

IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

March 15, 2022

Study Completion Date

May 1, 2022

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

interleuken 6 level measurment

Detection of IL6 level using ELISA technique.

DIAGNOSTIC_TEST

Interleukin-6 Gene-174C detection

The genotyping of the polymorphisms in IL-6 promoter G-174C (rs1800795) will be performed using PCR-RFLP technique.

Trial Locations (1)

31527

Bsant Safwat Kasem, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04544033 - IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients | Biotech Hunter | Biotech Hunter